Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4349 Target Snapshot

N-acylethanolamine-hydrolyzing acid amidase · SINGLE PROTEIN · Homo sapiens

517Compounds
65Assays
0Approved Drugs
594.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q02083. Use UniProt Q02083 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q02083 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats N-acylethanolamine-hydrolyzing acid amidase as ChEMBL target CHEMBL4349, mapped to UniProt Q02083. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
N-acylethanolamine-hydrolyzing acid amidase
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL4349
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q02083
N-acylethanolamine-hydrolyzing acid amidase
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether N-acylethanolamine-hydrolyzing acid amidase is the right protein anchor across sources, using UniProt Q02083 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelN-acylethanolamine-hydrolyzing acid amidase
UniProt AccessionQ02083
Component TypeProtein
Sequence Length359 aa

N-acylethanolamine-hydrolyzing acid amidase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as N-acylethanolamine-hydrolyzing acid amidase, mapped to UniProt Q02083. Sequence length is 359 aa.

Mapped IDQ02083
Review nameN-acylethanolamine-hydrolyzing acid amidase
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Phase III
2
Phase II
Assay Mix

Activity Type Distribution

IC50594.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4633233 9.46 IC50 0.35 Preclinical
CHEMBL4640552 9.34 IC50 0.46 Preclinical
CHEMBL4642793 9.33 IC50 0.47 Preclinical
CHEMBL4635208 9.17 IC50 0.68 Preclinical
CHEMBL4640519 9.07 IC50 0.85 Preclinical
CHEMBL4644090 9.06 IC50 0.88 Preclinical
CHEMBL4633213 9.05 IC50 0.89 Preclinical
CHEMBL4649536 9.03 IC50 0.94 Preclinical
CHEMBL4637701 8.99 IC50 1.03 Preclinical
CHEMBL4646880 8.96 IC50 1.1 Preclinical
Distribution

pChEMBL Value Distribution

32
5.0
37
5.5
97
6.0
62
6.5
137
7.0
48
7.5
44
8.0
13
8.5
9
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

65
Total Assays
406
Tested Compounds
1
Assay Types
Binding — 65 assays, 406 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 37 131 6.5
single protein format 25 203 7.2
assay format 3 72 6.0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine